Business vision - Pharmaceutical segment

 • Grow operating income 9% CAGR

 • Has been implemented necessary measures against severe NHI drug price revisions

 • Confident in overcoming tough environment

Core domain

 • Have competitive advantage

 • Being projected high market growth or substantial market size

Ethical pharmaceuticals

 ▸ Infectious diseases, generic drugs, biopharmaceuticals

 ▸ Expand both in Japan and overseas

 ▸ Become a leading company in Asia for the infectious disease

 ▸ Enhance production capacity, R&D, and promotional activities

Agricultural chemicals

 ▸ Extensive pipeline

 ▸ Expand overseas business